Impact of intracameral cefuroxime on the incidence of postoperative endophthalmitis following cataract surgery in Ireland
- 21 May 2014
- journal article
- research article
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 184 (2) , 395-398
Abstract
Postoperative endophthalmitis (PE) is a rare complication of cataract surgery, but carries a significant risk of blindness. The European Society of Cataract and Refractive Surgeons published a landmark study in 2007 that revealed the use of intracameral cefuroxime as prophylaxis against endophthalmitis reduced its incidence by fivefold. Since the publication of these results, the use of intracameral cefuroxime in cataract surgery has become a standard practice in many institutions, including our own. To identify the incidence rate of PE among patients undergoing cataract surgery over the 4-year period following the introduction of prophylactic intracameral cefuroxime for cataract surgery. A retrospective case note review of all cases of postoperative endophthalmitis that occurred between 2007 and 2011 was performed. Our results were compared with an earlier report on PE incidence rates from our institution that was conducted prior to the introduction of intracameral cefuroxime and published in 2001. There were five reported cases of endophthalmitis from 2007 to 2011 from a total of 8,239 cataract procedures, giving an incidence rate of 0.06 %. This compares with an incidence rate of 0.49 % in the earlier study prior to the introduction of intracameral cefuroxime and represents an eightfold reduction in the incidence of PE at our hospital. Of the five cases, three were confirmed on culture and sensitivity (two of which were due to Coagulase negative staphylococci and one due to Pseudomonas aeruginosa). The incidence of postoperative endophthalmitis has reduced by approximately eightfold since the introduction of intracameral cefuroxime following cataract surgery at our hospital in 2007. This study strongly supports the use of intracameral cefuroxime as prophylaxis against endophthalmitis in all cataract surgical cases.Keywords
This publication has 15 references indexed in Scilit:
- Epidemiology of postoperative endophthalmitis in an Asian population: 11-year incidence and effect of intracameral antibiotic agentsJournal of Cataract & Refractive Surgery, 2012
- Ocular toxicity after intracameral injection of very high doses of cefuroxime during cataract surgeryJournal of Cataract & Refractive Surgery, 2011
- Emerging antibiotic resistance in ocular infections and the role of fluoroquinolonesJournal of Cataract & Refractive Surgery, 2010
- Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgeryJournal of Cataract & Refractive Surgery, 2010
- An Outbreak of Post-Cataract Surgery Endophthalmitis Caused by Pseudomonas aeruginosaOphthalmology, 2009
- An Outbreak of Early-Onset Endophthalmitis Caused byFusariumSpecies following Cataract SurgeryCurrent Eye Research, 2009
- Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factorsJournal of Cataract & Refractive Surgery, 2007
- Reducing the risk for endophthalmitis after cataract surgery: Population-based nested case-control studyJournal of Cataract & Refractive Surgery, 2007
- Incidence of presumed postoperative endophthalmitis in Dublin for a 5-year period (1997–2001)Journal of Cataract & Refractive Surgery, 2005
- Endophthalmitis caused by Pseudomonas aeruginosaOphthalmology, 2003